High spending indicates growth investment, while low spending may signal a focus on cash preservation or asset maturity.
This metric tracks cash outflows dedicated to the purchase of property, plant, equipment, or other long-term assets nece...
Comparable to 'Capital Expenditures' or 'Purchase of Property, Plant, and Equipment' in the investing section.
cvx_payments_to_acquire_other_productive_assets| Segment | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| U.S. Pharmaceutical | $38.50M | $38.50M | $48.25M | $48.25M | $48.25M | $48.25M | $28.00M | $73.00M |
| Medical-Surgical Solutions | $29.25M | $29.25M | $39.75M | $39.75M | $39.75M | $39.75M | $51.00M | $25.00M |
| International | $19.75M | $19.75M | $18.75M | $18.75M | $18.75M | $18.75M | $25.00M | $13.00M |
| Total | — | — | — | — | — | — | — | — |
International, Medical-Surgical Solutions, U.S. Pharmaceutical were previously reported and have since been discontinued or reclassified. Only currently active segments are shown in the chart.